<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel rdf:about="http://localhost:80/xmlui/handle/123456789/13306">
    <title>DSpace Collection:</title>
    <link>http://localhost:80/xmlui/handle/123456789/13306</link>
    <description />
    <items>
      <rdf:Seq>
        <rdf:li rdf:resource="http://localhost:80/xmlui/handle/123456789/13635" />
        <rdf:li rdf:resource="http://localhost:80/xmlui/handle/123456789/13589" />
        <rdf:li rdf:resource="http://localhost:80/xmlui/handle/123456789/13588" />
        <rdf:li rdf:resource="http://localhost:80/xmlui/handle/123456789/13587" />
      </rdf:Seq>
    </items>
    <dc:date>2026-04-23T18:56:54Z</dc:date>
  </channel>
  <item rdf:about="http://localhost:80/xmlui/handle/123456789/13635">
    <title>Piroxicam loaded polymer hybrid microspheres based tablets with modified release kinetics: Development, characterization and in vivo evaluation</title>
    <link>http://localhost:80/xmlui/handle/123456789/13635</link>
    <description>Title: Piroxicam loaded polymer hybrid microspheres based tablets with modified release kinetics: Development, characterization and in vivo evaluation
Authors: Hamid, Hajra Afeera; Khan, Shahzeb; Shah, Syed Muhammad Noor; Asghar, Muhammad; Shahid, Muhammad; Hussain, Zahid; Sohail, Muhammad; Barkat, Ali Khan; Amin, Fazli; Jan, Syed Umer; Elhissi, Abdelbary; Shah, Syed Muhammad Hassan; Minhas, Muhammad Usman; Shah, Syed Wadood Ali; Ahmad, Naveed
Abstract: Piroxicam (PC) is a non-steroidal anti-inflammatory drug characterized by poor aqueous solubility and&#xD;
reported to cause and impart crucial GIT irritation, bleeding, peptic and duodenal ulcer. Engineering of PC loaded&#xD;
microcapsules and its surface modification using different polymers has become the popular approach to address the said&#xD;
issues. The purpose of the study was to develop new PC loaded gastro-protective polymer hybrid microspheres (PHM)&#xD;
with subsequent conversion to tablet dosage form having modified dissolution rate and improved bioavailability. The&#xD;
crystallinity of the PC loaded PHM were established through powder X-ray diffraction. The optimised microspheres, PCM1 with particle size 32±3.0µm, entrapment efficiency 83.78±2.5% and in vitro drug release 87.1±2.6% were further&#xD;
subjected to tablets development and in vivo evaluation. The in vitro drug release study conducted for PHM at pH media&#xD;
1.2 and 6.8 demonstrated retarded and enhanced drug release rates (P&lt;0.001) respectively. Both accelerated and real&#xD;
time stability studies confirmed stability of the PC loaded PHM based tablets. A substantial improvement in the drug&#xD;
plasma concentration 12.6±2.36 (P&lt;0.001) was observed for the produced tablets compared to the marketed&#xD;
formulations.</description>
    <dc:date>2021-01-16T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://localhost:80/xmlui/handle/123456789/13589">
    <title>Cardiotonic potential of Carissa opaca Stapf ex Haines: A study on isolated rabbit heart</title>
    <link>http://localhost:80/xmlui/handle/123456789/13589</link>
    <description>Title: Cardiotonic potential of Carissa opaca Stapf ex Haines: A study on isolated rabbit heart
Authors: Alqahtani, Yahya S; Amir, Huma; Alamgeer; Ahmad, Taseer; Mahnashi, Mater H; Alyami, Bandar A; Alqarni, Ali O; Akram, Muhammad; Khan, Hafeez Ullah
Abstract: : Carissa opaca (C.O) is a wild shrub, belonging to the family Apocynaceae. The medicinal virtues of this plant&#xD;
have long been known. The present study demonstrates the effects of aqueous-methanolic extract and various fractions&#xD;
(n-butanolic and aqueous) of Carissa opaca on cardiovascular parameters. The perfusion pressure (PP), force of&#xD;
contraction (FC) and heart rate (HR) were assessed on isolated heart of rabbit using Langendroff’s technique for crude&#xD;
extract and fractions of C.O, followed by the elucidation of the mechanism of action after estimating toxicity of the plant.&#xD;
Negative ionotropic and positive chronotropic effects, with an increase in PP in isolated perfused rabbit heart were&#xD;
observed the with plant extract and fractions. The aqueous-methanolic extract exhibited maximum response at 1mg/ml&#xD;
while the n-butanolic and aqueous fractions showed a maximum response at 1mg/ml and 10µg/ml respectively. Both&#xD;
fractions produced the same response when treated with atropine (10-5 M), however the actions of adrenaline (10-5 M)&#xD;
and calcium chloride (10-5 M) remained unblocked. Acute toxicity studies indicated that the plant was safe up to 2000&#xD;
mg/kg and sub-chronic studies demonstrated that no significant change in haematological and biochemical parameters&#xD;
observed. In conclusion, this study supports the folkloric claim of C.O extract.</description>
    <dc:date>2021-01-16T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://localhost:80/xmlui/handle/123456789/13588">
    <title>Cardioprotective effect of boswellic acids against doxorubicin induced myocardial infarction in rats</title>
    <link>http://localhost:80/xmlui/handle/123456789/13588</link>
    <description>Title: Cardioprotective effect of boswellic acids against doxorubicin induced myocardial infarction in rats
Authors: Shahid, Muhammad Hassaan; Anjum, Irfan; Mushtaq, Muhammad Naveed; Riaz, Saba
Abstract: The aim of the present study was to evaluate the cardioprotective activity of boswellic acids in doxorubicin&#xD;
(DOX) induced cardiotoxicity. DOX (2.5mg/kg) was used intraperitoneally in rats to induce cardiotoxicity in six divided&#xD;
doses every alternate day over a period of two weeks. Dexrazoxane (10:1) was used as a standard drug. Boswellic acids&#xD;
(250, 500 and 750 mg/kg) were orally administered to rats for 14 days. After 14 days, rats were sacrificed, and blood was&#xD;
withdrawn through cardiac puncture. The blood lipid profile and cardiac biomarkers including LDH, CK-MB, CPK,&#xD;
SGOT and troponin T were measured. The heart of rats was isolated for histopathological studies. Graphpad Prism was&#xD;
used for statistical analysis. There was a significant increase in the level of cardiac enzymes and complete lipid profile&#xD;
parameters in diseased group as compared to control group. Pre-treatment with boswellic acids decreased level of all the&#xD;
measured parameters and decreased the severity of myocardial damage as supported by histopathological studies. It was&#xD;
concluded that boswellic acids possess cardioprotective potential by lowering cardiac biomarkers and blood lipid profile.&#xD;
Thus, boswellic acids might act as cardioprotective agent against doxorubicin induced cardiotoxicity.</description>
    <dc:date>2021-01-16T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://localhost:80/xmlui/handle/123456789/13587">
    <title>Synthesis and anticancer evaluation of 2-oxo-2-(arylamino) ethyl 4- phenylpiperazine-1-carbodithioates</title>
    <link>http://localhost:80/xmlui/handle/123456789/13587</link>
    <description>Title: Synthesis and anticancer evaluation of 2-oxo-2-(arylamino) ethyl 4- phenylpiperazine-1-carbodithioates
Authors: Hafeez, Freeha; Zahoor, Ameer Fawad; Rasul, Azhar; Ahmad, Sajjad; Mansha, Asim
Abstract: Piperazine moiety is found as an efficient pharmacological scaffold in various drugs. To explore the&#xD;
anticancer potential of piperazine framework, a series of novel N-acetamides derivatives of phenyl piperazine containing&#xD;
di-thio-carbamate moiety was designed and synthesized. 1HNMR, 13CNMR, FT-IR and mass spectrometry were used for&#xD;
the structures elucidation of these derivatives. In-vitro cytotoxic evaluation of the prepared novel compounds against&#xD;
lung carcinoma A-549 was carried out using standard MTT assay. All the di-thio-carbamate-piperazine derivatives&#xD;
exhibited moderate to excellent cytotoxic potential against A-549 cell line based on cell viability. Particularly, 6e was&#xD;
found to be the most potent derivative with cell viability 34.12±0.73 % at 100 µg/mL concentration and represents&#xD;
promising lead compound for future progress.</description>
    <dc:date>2021-01-16T00:00:00Z</dc:date>
  </item>
</rdf:RDF>

